Search Results
Results found for "Martin Audet"
- Genome-wide identification of 216 G protein-coupled receptor (GPCR) genes from the marine water ...
Genome-wide identification of 216 G protein-coupled receptor (GPCR) genes from the marine water flea Here, we identified a total 216 full-length GPCR genes in the marine water flea Diaphanosoma celebensis
- Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids
We have carried out MARTINI coarse-grained molecular dynamics simulations of SMO in POPC and in ciliary
- Ode to GPCRs
The 1994 Nobel Prize in Physiology or Medicine was awarded to Alfred Goodman Gilman and Martin Rodbell Martin Rodbell – Facts - NobelPrize.org. https://www.nobelprize.org/prizes/medicine/1994/rodbell/facts Martin Rodbell – Nobel Lecture - NobelPrize.org. https://www.nobelprize.org/prizes/medicine/1994/rodbell
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
For drug discovery teams navigating safety margins, biased signaling, and combination therapy design, Recognizing how your ligand interacts with the receptor lets you predict safety margins, dose–response
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
How does this translate into a clear safety margin? These aren’t just documentation issues. FDA is actually optimizing for, and where most early-stage teams fall short: 1️⃣ Predictable safety margins
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
. 🚀 Book your free 30-minute precision audit — before your next DMTA cycle costs another $200K Let’
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
.; Martin, B. R.; Abood, M. E. J Pharmacol Exp Ther 1996 , 278 (3), 989–999. (12) Martín-Fontecha, M.; Angelina, A.; Rückert , B.; Rueda-Zubiaurre, A.; Martín-Cruz, L.; Van De Veen, W.; Akdis, M.; Ortega-Gutiérrez, S.; López-Rodríguez
- Unlocking the Future of Medicine: Advancements in GPCR Research
Elucidation, and Biological Activity of the Selective TACR2 Antagonist Tumonolide and its Aldehyde from a Marine disordered C-terminal domains Industry News Novartis continues to deliver strong sales growth and core margin
- Chemokine receptor-targeted drug discovery: progress and challenges
In fact, the requirements in terms of safety margin, oral bioavailability, and frequency of administration
